5EI-Maqsoud NA, EI-Gelany S. Differential expression patterns of PTEN in cyclic, hyperplastic and malignant endometrium: its relation with ER, PR and clinicopathalogical parameters [ J ]. J Egypt Natl Canc lnst, 2009, 21 (4) :323 -331.
6Brandenberger AW, Lebovic DI, Tee MK, et al. Oestrogen receptor (ER)-and ER-13 isoforms in normal endometrial and endometriosis-derived stromal cells [ J ]. Mol Hum Reprod, 1999,5 (7) : 651 - 655.
7Misiti S, Schomburg L, Yen PM, et al. Expression and hormonal regulation of coactivator and corepressor genes [ J ]. Endocrinology, 1998, 139(5) :2493 -2500.
8Redmond AM, Bane FT, Stafford AT, et al. Coassociation of estro- gen receptor and p160 proteins predicts resistance to endocrine treat- ment; SRC-1 is an independent predictor of breast cancer recurrence [J]. Clin Cancer Res, 2009, 15(6) :2098 -2106.
9Karmakar S, Foster EA, Smith CL. Unique roles of p160 coactivators for regulation of breast cancer cell proliferation and estrogen recep- tor-transcriptional activity [ J ]. Endocrinology, 2009, 150 ( 4 ) : 1588 - 1596.
10Oberoi J, Faira11 L, Watson PJ, et al. Structural basis for the assem- bly of the SMRT/NCoR core transcriptional repression machinery [J]. Nat Struct Mol Biol, 2011, 18(2) : 177 - 184.
